Avenue Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Robert Davidow(2.9%)
Avenue Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(8.0%)
Avenue Therapeutics | 4:持股變動聲明-股東 Fortress Biotech, Inc.
Avenue Therapeutics | 4:持股變動聲明-股東 Fortress Biotech, Inc.
Avenue Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)
Avenue Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Robert Davidow(9.89%)
Avenue Therapeutics | 4:持股變動聲明-股東 Davidow Robert L
Avenue Therapeutics | SC 13G:超過5%持股股東披露文件-Robert Davidow(14.5%)
Avenue Therapeutics | 3:首次持股聲明-股東 Davidow Robert L
Avenue Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Fortress Biotech, Inc.(12.1%)
Avenue Therapeutics | 4:持股變動聲明-董事 ROSENWALD LINDSAY A MD
Avenue Therapeutics | 4:持股變動聲明-股東 Fortress Biotech, Inc.
Avenue Therapeutics | 4:持股變動聲明-董事 Charles Faith L.
Avenue Therapeutics | 4:持股變動聲明-高管 Jin David
Avenue Therapeutics | 4:持股變動聲明-董事 ROSENWALD LINDSAY A MD
Avenue Therapeutics | 4:持股變動聲明-董事 KRANZLER JAY D
Avenue Therapeutics | 4:持股變動聲明-董事 Oltmans Curtis Gale
Avenue Therapeutics | 4:持股變動聲明-董事 Herskowitz Neil
Avenue Therapeutics | 4:持股變動聲明-首席執行官 MacLean Alexandra
Avenue Therapeutics | 4:持股變動聲明-股東 Fortress Biotech, Inc.
暫無數據